MENU

What we learned from our DNA; Making Cannabis Personal

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • CEO and Co-Founder, Endocanna Health
    Biography

      Mr. May brings more than 25 years of cannabis and genomics experience to Endocanna Health. A pioneer in the medical cannabis industry, May has been instrumental in shaping the current legislation and culture. He has held past positions as President of the Cannabis Action Network and ​Board Member and Lifetime Member of California Cannabis Association. May is the current chair of the CBDIA science board, and is a ​stakeholder in some of the industry’s most iconic brands. His areas of expertise include the workings of the E​ ndocannabinoid system and how genetic expression plays a role in human experiences. A​ s a Certified Medical Cannabis Specialist in Medicinal Genomics, May has an in-depth knowledge of genomics, cannabinoids and terpenes, and their interaction with the endocannabinoid system. As well, he holds a Masters of Medical Cannabis and a certificate in Endocannabinoid Formulation from the Institute for the Advancement of Integrative Medicine. Mr. May is an accomplished public speaker having presented on these topics on some of the world’s most prestigious stages in his mission to help educate the population about the healing powers of cannabis. A published author “ Making Cannabis Personal” and the host of the popular “Everything is Personal” podcast.


    Abstract

    Genetics may influence experience with cannabis and CBD. With increased access to legal cannabis and the research community expanding their focus on the medicinal uses of cannabinoids, more and more consumers are seeking cannabis for health and wellness. However, cannabinoids are extremely complex partners for our endocannabinoid system and research tells us that users can have vastly different physiological responses to individual strains or products. This makes it almost impossible to find a perfectly aligned product through trial and error. The truth is, cannabis is personal, and uncovering true endocompatibility for each individual user can be scientifically validated.

    Learning Objectives:

    1. Introduce listeners to the complexities of the endocannabinoid system and the role DNA plays in optimizing cannabinoid experiences

    2. Discuss the breakthrough scientific approach Endocanna Health has taken to solving for an individualized response to cannabinoids

    3. Address the significant barriers that both consumers and medical professionals experience when incorporating cannabinoid therapeutics into treatment protocols (safety, efficacy, consistency)

    4. Discuss the latest research and scientific evidence to evaluate and confidently use cannabinoid therapeutics for individually defined optimal outcomes

    5. Explain the scientifically based, genetically focused resource that consistently and reliably matches individuals with the most compatible cannabinoid products


    Show Resources
    You May Also Like
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    JAN 21, 2021 8:00 AM PST
    JAN 21, 2021 8:00 AM PST
    Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    Loading Comments...
    Show Resources
    Attendees
    • See more